QT
VIVO

Quantamental Technologies’s Meridian Bioscience Inc VIVO Stock Holding History

Quantamental Technologies’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-10,339
Closed -$241K – 397
2020
Q2 		$241K Buy
+10,339
New +$150K 0.16% 206
2019
Q2 		– Sell
-3,179
Closed -$56K – 1908
2019
Q1 		$56K Buy
+3,179
New +$52.9K 0.03% 828

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Quantamental Technologies's VIVO Position: Q3 2020 in Review

Quantamental Technologies sold out of Meridian Bioscience Inc (VIVO) in Q3 2020, closing a stake of 10,339 shares — an estimated $241K sold.

Quantamental Technologies first reported a position in VIVO in Q1 2019 and held it in 2 quarters. The position peaked at $241K in Q2 2020. 191 funds tracked by Wall St. Rank hold VIVO as of Q3 2020.

  • Quantamental Technologies reported no remaining Meridian Bioscience Inc position as of Q3 2020 after selling out during the quarter.
  • Quantamental Technologies sold 10,339 Meridian Bioscience Inc shares in Q3 2020, an estimated $241K.
  • Quantamental Technologies first reported a position in Meridian Bioscience Inc in Q1 2019 and held it in 2 quarters.
  • Quantamental Technologies's Meridian Bioscience Inc position peaked at $241K in Q2 2020.
  • 191 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2020.

Based on Quantamental Technologies's 13F filing for Q3 2020, filed 16 Nov 2020.